DUBLIN, IRELAND , Jan. 30, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on February 23, 2024. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services tha ...

DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.   A press release detailing financial results will b ...

STERIS plc (STE) is well-poised to grow in the coming quarters, backed by its advancements in the healthcare and pharmaceutical industries. The widespread market acceptance of its diverse offerings is driving growth in the Healthcare business. The company is also solvent enough to meet its near-term debt obligations. However, macroeconomic constraints challenge STERIS’ operations, while competitive disadvantages remain a concern. In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 14% ...

STERIS plc (NYSE:STE) Q2 2024 Earnings Conference Call November 8, 2023 9:00 AM ET Company Participants Julie Winter - Vice President of Investor Relations Dan Carestio - President and CEO Mike Tokich - Senior Vice President and CFO Conference Call Participants Jacob Johnson - Stephens, Inc. David Turkaly - JMP Securities Michael Polark - Wolfe Research Michael Matson - Needham & Company Jason Bednar - Piper Sandler Operator Good morning, everyone and welcome to the STERIS plc Fiscal Second Quarter 2024 Con ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-145506 ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) (State or other jurisd ...

STERIS plc (NYSE:STE) Q1 2024 Earnings Conference Call August 2, 2023 9:00 AM ET Company Participants Julie Winter - VP, IR & Corporate Communications Michael Tokich - SVP & CFO Daniel Carestio - President, CEO & Director Conference Call Participants Matthew Mishan - KeyBanc Capital Markets David Turkaly - JMP Securities Michael Matson - Needham & Company Patrick Wood - Morgan Stanley Michael Polark - Wolfe Research Jason Bednar - Piper Sandler & Co. Operator Good day, and welcome to the STERIS plc First Qu ...

United States Securities and Exchange Commission Washington, D. C. 20549 ________________________________________________ FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the fiscal year ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 (State or other jurisdiction ...

STERIS plc (NYSE:STE) Q4 2023 Earnings Conference Call May 11, 2023 9:00 AM ET Company Participants Julie Winter - IR Daniel Carestio - President and CEO Michael Tokich - SVP and CFO Conference Call Participants Matthew Mishan - KeyBanc Dave Turkaly - JMP Securities Mike Matson - Needham & Company Michael Polark - Wolfe Research Jason Bednar - Piper Sandler Operator Good morning and welcome to the STERIS plc Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] Please also note, this event i ...

STERIS plc (NYSE:STE) Q3 2023 Earnings Conference Call February 9, 2023 10:00 AM ET Company Participants Julie Winter - IR Daniel Carestio - President and CEO Michael Tokich - SVP and CFO Conference Call Participants Dave Turkaly - JMP Securities Matthew Mishan - KeyBanc Jacob Johnson - Stephens Mike Matson - Needham & Company Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Matthew Mishan - KeyBanc Operator Good day, everyone, and welcome to the STERIS plc Third Quarter 2023 Conference Call. [O ...